Association of Persistent Symptoms after Lyme Neuroborreliosis and Increased Levels of Interferon-α in Blood

Patients who have Lyme neuroborreliosis (LNB) might experience lingering symptoms that persist despite antibiotic drug therapy. We tested whether those symptoms are caused by maladaptive immune responses by measuring 20 immune mediators in serum and cerebrospinal fluid (CSF) in 79 LNB patients foll...

Full description

Bibliographic Details
Main Authors: Sergio A. Hernández, Katarina Ogrinc, Miša Korva, Andrej Kastrin, Petra Bogovič, Tereza Rojko, Keith W. Kelley, Janis J. Weis, Franc Strle, Klemen Strle
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2023-06-01
Series:Emerging Infectious Diseases
Subjects:
Online Access:https://wwwnc.cdc.gov/eid/article/29/6/22-1685_article
_version_ 1797823556447371264
author Sergio A. Hernández
Katarina Ogrinc
Miša Korva
Andrej Kastrin
Petra Bogovič
Tereza Rojko
Keith W. Kelley
Janis J. Weis
Franc Strle
Klemen Strle
author_facet Sergio A. Hernández
Katarina Ogrinc
Miša Korva
Andrej Kastrin
Petra Bogovič
Tereza Rojko
Keith W. Kelley
Janis J. Weis
Franc Strle
Klemen Strle
author_sort Sergio A. Hernández
collection DOAJ
description Patients who have Lyme neuroborreliosis (LNB) might experience lingering symptoms that persist despite antibiotic drug therapy. We tested whether those symptoms are caused by maladaptive immune responses by measuring 20 immune mediators in serum and cerebrospinal fluid (CSF) in 79 LNB patients followed for 1 year. At study entry, most mediators were highly concentrated in CSF, the site of the infection. Those responses resolved with antibiotic therapy, and associations between CSF cytokines and signs and symptoms of LNB were no longer observed. In contrast, subjective symptoms that persisted after use of antibiotics were associated with increased levels of serum interferon-α (IFN-α), which were already observed at study entry, and remained increased at each subsequent timepoint. Highest IFN-α levels corresponded with severe disease. Although the infection serves as the initial trigger, sequelae after antibiotic therapy are associated with unremitting systemic IFN-α levels, consistent with the pathogenic role of this cytokine in interferonopathies in other conditions.
first_indexed 2024-03-13T10:25:40Z
format Article
id doaj.art-4ffc9c3c8ef34effa218f0f7b8bb57cb
institution Directory Open Access Journal
issn 1080-6040
1080-6059
language English
last_indexed 2024-03-13T10:25:40Z
publishDate 2023-06-01
publisher Centers for Disease Control and Prevention
record_format Article
series Emerging Infectious Diseases
spelling doaj.art-4ffc9c3c8ef34effa218f0f7b8bb57cb2023-05-19T12:22:55ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592023-06-012961091110110.3201/eid2906.221685Association of Persistent Symptoms after Lyme Neuroborreliosis and Increased Levels of Interferon-α in BloodSergio A. HernándezKatarina OgrincMiša KorvaAndrej KastrinPetra BogovičTereza RojkoKeith W. KelleyJanis J. WeisFranc StrleKlemen Strle Patients who have Lyme neuroborreliosis (LNB) might experience lingering symptoms that persist despite antibiotic drug therapy. We tested whether those symptoms are caused by maladaptive immune responses by measuring 20 immune mediators in serum and cerebrospinal fluid (CSF) in 79 LNB patients followed for 1 year. At study entry, most mediators were highly concentrated in CSF, the site of the infection. Those responses resolved with antibiotic therapy, and associations between CSF cytokines and signs and symptoms of LNB were no longer observed. In contrast, subjective symptoms that persisted after use of antibiotics were associated with increased levels of serum interferon-α (IFN-α), which were already observed at study entry, and remained increased at each subsequent timepoint. Highest IFN-α levels corresponded with severe disease. Although the infection serves as the initial trigger, sequelae after antibiotic therapy are associated with unremitting systemic IFN-α levels, consistent with the pathogenic role of this cytokine in interferonopathies in other conditions. https://wwwnc.cdc.gov/eid/article/29/6/22-1685_articleLyme neuroborreliosispersistent symptomsLyme diseaseimmune responseinflammationinterferon-alpha
spellingShingle Sergio A. Hernández
Katarina Ogrinc
Miša Korva
Andrej Kastrin
Petra Bogovič
Tereza Rojko
Keith W. Kelley
Janis J. Weis
Franc Strle
Klemen Strle
Association of Persistent Symptoms after Lyme Neuroborreliosis and Increased Levels of Interferon-α in Blood
Emerging Infectious Diseases
Lyme neuroborreliosis
persistent symptoms
Lyme disease
immune response
inflammation
interferon-alpha
title Association of Persistent Symptoms after Lyme Neuroborreliosis and Increased Levels of Interferon-α in Blood
title_full Association of Persistent Symptoms after Lyme Neuroborreliosis and Increased Levels of Interferon-α in Blood
title_fullStr Association of Persistent Symptoms after Lyme Neuroborreliosis and Increased Levels of Interferon-α in Blood
title_full_unstemmed Association of Persistent Symptoms after Lyme Neuroborreliosis and Increased Levels of Interferon-α in Blood
title_short Association of Persistent Symptoms after Lyme Neuroborreliosis and Increased Levels of Interferon-α in Blood
title_sort association of persistent symptoms after lyme neuroborreliosis and increased levels of interferon α in blood
topic Lyme neuroborreliosis
persistent symptoms
Lyme disease
immune response
inflammation
interferon-alpha
url https://wwwnc.cdc.gov/eid/article/29/6/22-1685_article
work_keys_str_mv AT sergioahernandez associationofpersistentsymptomsafterlymeneuroborreliosisandincreasedlevelsofinterferonainblood
AT katarinaogrinc associationofpersistentsymptomsafterlymeneuroborreliosisandincreasedlevelsofinterferonainblood
AT misakorva associationofpersistentsymptomsafterlymeneuroborreliosisandincreasedlevelsofinterferonainblood
AT andrejkastrin associationofpersistentsymptomsafterlymeneuroborreliosisandincreasedlevelsofinterferonainblood
AT petrabogovic associationofpersistentsymptomsafterlymeneuroborreliosisandincreasedlevelsofinterferonainblood
AT terezarojko associationofpersistentsymptomsafterlymeneuroborreliosisandincreasedlevelsofinterferonainblood
AT keithwkelley associationofpersistentsymptomsafterlymeneuroborreliosisandincreasedlevelsofinterferonainblood
AT janisjweis associationofpersistentsymptomsafterlymeneuroborreliosisandincreasedlevelsofinterferonainblood
AT francstrle associationofpersistentsymptomsafterlymeneuroborreliosisandincreasedlevelsofinterferonainblood
AT klemenstrle associationofpersistentsymptomsafterlymeneuroborreliosisandincreasedlevelsofinterferonainblood